HAUS augmin like complex subunit 6 pseudogene 3Genealiases: []
Q-omics provides the consensus-scored HAUS6P3 profile across patient tissues and cancer cell-line models. HAUS6P3 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in CESC. Among the 18 cancer types available for tumor–normal comparison, HAUS6P3 is differentially expressed in 5, with the highest sampling consensus in STAD. Additionally, HAUS6P3 RNA expression shows 7,659 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight CESC, STAD, and UVM as cancer lineages where HAUS6P3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for HAUS6P3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes HAUS6P3 survival associations across molecular data types. HAUS6P3 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible HAUS6P3 RNA expression–survival associations across cancer types. High HAUS6P3 expression shows unfavorable associations in LUSC, ACC, CHOL, UCEC and UVM, but favorable associations in CESC. The CESC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .003). Together, the overview and detailed table identify CESC as the clearest survival context for HAUS6P3 RNA expression.
This table summarizes HAUS6P3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for HAUS6P3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. HAUS6P3 shows higher tumor expression in STAD, HNSC, BRCA, COAD and LUAD. The STAD box plot shows higher HAUS6P3 RNA expression in tumor versus normal tissue (log2 FC = +0.172, t-test p < 0.001).
This table shows molecular features associated with HAUS6P3 in patient tissues and cancer cell lines. In patient samples, HAUS6P3 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
